Disease/Infection News

RSS

Earlier 'Test, Trace, Isolate' on Isle of Wight reduced COVID-19 incidence and R0

Researchers in the UK report that the incidence of new coronavirus disease 2019 (COVID-19) cases fell in the Isle of Wight following the launch of a new “Test, Trace, Isolate (TTI)” program on May 5th that included the option of using an NHS Smartphone app.

15 Jul 2020

Report offers insight into loneliness and social isolation in older adults during COVID-19 pandemic

A joint report published by researchers at the Irish Longitudinal Study on Ageing (TILDA) and ALONE examines issues of loneliness and social isolation in older adults.

15 Jul 2020

Model suggests U.S. opened up too early as COVID-19 ran wild

A new modeling framework designed to track the transmission of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in the U.S. suggests that the coronavirus disease 2019 (COVID-19) epidemic was not under control by the end of May - just before containment measures were relaxed.

15 Jul 2020

COVID-19 rates among health care workers drop at Mass General Brigham after universal masking

In March of 2020, Mass General Brigham implemented a new policy: everyone working at the hospitals would be required to wear a surgical mask.

15 Jul 2020

States slow to implement social distancing measures saw higher COVID-19 mortality

As the COVID-19 pandemic spread across the United States, governments at the state and local levels issued emergency declarations and shut down schools.

15 Jul 2020

New immune profiles could help predict disease trajectory in severe COVID-19 patients

Researchers from the Penn Institute of Immunology discovered three distinct immune responses to the SARS-CoV2 infection that could help predict the trajectory of disease in severe COVID-19 patients and may ultimately inform how to best treat them.

15 Jul 2020

Study explains why fetuses and newborns are mostly spared by COVID-19

Amid the coronavirus pandemic, it has been previously suggested that the most vulnerable individuals to developing severe coronavirus disease (COVID-19) include the elderly, those with underlying health conditions, and those who have weakened immune systems.

15 Jul 2020

Buck researchers investigate ketone bodies as possible therapeutic against COVID-19

Given the disproportionate impact that COVID-19 has on older adults in terms of death and lasting disability, and the impact of common aging-related comorbidities like diabetes and cardiovascular disease, Buck Institute professor and practicing geriatrician John Newman, MD, PhD, can make a compelling argument that those infected with the SARS-CoV2 virus are suffering from an aging-related disease, no matter how old they are when they get infected.

15 Jul 2020

Moderna vaccine induces robust immune response against SARS-CoV-2

The race to develop an effective vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is on, and one of the potential candidates shows promise in inducing an immune response.

15 Jul 2020

Study provides new insights into genetic susceptibility of COVID-19

A new Cleveland Clinic study has identified genetic factors that may influence susceptibility to COVID-19. Published today in BMC Medicine, the study findings could guide personalized treatment for COVID-19.

15 Jul 2020

Novel surface coating inactivates SARS-CoV-2 in one hour

Door knobs, light switches, shopping carts. Fear runs rampant nowadays when it comes to touching common surfaces because of the rapid spread of the coronavirus.

15 Jul 2020

Georgia State professor receives federal funding to study unique features of Ebola, Marburg viruses

Dr. Christopher Basler, professor and director of the Center for Microbial Pathogenesis in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.94 million federal grant to study unique features of Ebola and Marburg viruses that control how the virus family expresses its genes and escapes immune responses.

15 Jul 2020

Common FDA-approved drug may be a powerful tool in fighting COVID-19

A common drug, already approved by the Food and Drug Administration, may also be a powerful tool in fighting COVID-19, according to research published this week in Antiviral Research.

15 Jul 2020

UC study tests efficacy of immune regulating drug in treating patients with COVID-19 pneumonia

Researchers at the University of Cincinnati are testing a commonly used drug, called sirolimus, to determine its safety and efficacy in treating hospitalized patients with COVID-19 pneumonia in the trial.

15 Jul 2020

Nanotechnology plays major role in COVID-19 vaccine development

From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the headlines.

15 Jul 2020

Anti-inflammatory medication helps fight dangerous immune response in COVID-19 patients

Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug Administration-approved drug normally given for rheumatoid arthritis, according to an observational study at Cedars-Sinai.

15 Jul 2020

Global negative sentiments surrounding COVID-19 shift from fear to anger, study finds

The fear that people developed at the start of the COVID-19 outbreak has given way to anger over the course of the pandemic, a study of global sentiments led by Nanyang Technological University, Singapore (NTU Singapore) has found.

15 Jul 2020

New trial investigates if prostate cancer drug can be used to treat COVID-19

In a new trial, Swedish researchers will investigate if a medicine normally used to treat prostate cancer can also be used to treat COVID-19 in patients.

15 Jul 2020

Cholesterol-lowering drugs show promise to lower COVID-19's threat

Could a simple drug, that has been on the market for decades, be used to treat COVID-19? A research team led by Hebrew University of Jerusalem (HU)'s Professor Yaakov Nahmias says that early research looks promising; their findings appear in this week's Cell Press' Sneak Peak.

15 Jul 2020

BATM introduces three new diagnostic kits for COVID-19 and other respiratory illness

BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces the launch of three new diagnostic kits to significantly advance the diagnosis of COVID-19 and other respiratory illnesses.

15 Jul 2020

Disease/Infection News

Earlier 'Test, Trace, Isolate' on Isle of Wight reduced COVID-19 incidence and R0

Report offers insight into loneliness and social isolation in older adults during COVID-19 pandemic

Model suggests U.S. opened up too early as COVID-19 ran wild

COVID-19 rates among health care workers drop at Mass General Brigham after universal masking

States slow to implement social distancing measures saw higher COVID-19 mortality

New immune profiles could help predict disease trajectory in severe COVID-19 patients

Study explains why fetuses and newborns are mostly spared by COVID-19

Buck researchers investigate ketone bodies as possible therapeutic against COVID-19

Moderna vaccine induces robust immune response against SARS-CoV-2

Study provides new insights into genetic susceptibility of COVID-19

Novel surface coating inactivates SARS-CoV-2 in one hour

Georgia State professor receives federal funding to study unique features of Ebola, Marburg viruses

Common FDA-approved drug may be a powerful tool in fighting COVID-19

UC study tests efficacy of immune regulating drug in treating patients with COVID-19 pneumonia

Nanotechnology plays major role in COVID-19 vaccine development

Anti-inflammatory medication helps fight dangerous immune response in COVID-19 patients

Global negative sentiments surrounding COVID-19 shift from fear to anger, study finds

New trial investigates if prostate cancer drug can be used to treat COVID-19

Cholesterol-lowering drugs show promise to lower COVID-19's threat

BATM introduces three new diagnostic kits for COVID-19 and other respiratory illness

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News